The pineal gland and cancer

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 2033-2039

  Ronco, Alvaro L ^a,c   Halberg, Franz ^b  

^a National Institute of Oncology   (Uruguay)

^b UNIVERSITY OF MINNESOTA   (United States)

^c National Institute of Oncology   (Uruguay)

Author keywords

Cancer; Electromagnetic fields; Melatonin; Pineal

Indexed keywords

MELATONIN; PINEAL BODY HORMONE;

ARTICLE; CANCER PATIENT; CIRCADIAN RHYTHM; ELECTROMAGNETIC FIELD; HORMONAL CARCINOGENESIS; HORMONE METABOLISM; HUMAN; IMMUNOMODULATION; NEUROENDOCRINOLOGY; PINEAL BODY; PRIORITY JOURNAL;

ANIMALS; CIRCADIAN RHYTHM; ELECTROMAGNETIC FIELDS; FEMALE; HUMANS; MALE; MELATONIN; MODELS, BIOLOGICAL; NEOPLASMS; PINEAL GLAND;

EID: 0029741983     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Wurtman R, Cardinali D: The pineal organ. In: Textbook of endocrinology (Williams R, ed.), Philadelphia 1974, W.B.Saunders, p. 832.
2. Vacas M, Ritta M, Cardinali D: The pineal gland. In: Hypothalamus-hypuphysis unit (Guitelman A & cols, eds.), Buenos Aires, Edimed, 1983, pp.29-34 (In Spanish).
3. Rusak B, Zucer I: Neural regulation of circadian rhythms. Physiol Rev 59: 449-526, 1979.
4. Sharma M, Palacios J, Schwartz G, Iskandar H, Thakur M, Quirion R and Nair NP: Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry 25(3): 305-319, 1989.
5. Lincoln G, Ebling F, Almeida O: Generation of melatonin rhythms. In: Photoperiodism, melatonin and the pineal, Ciba Foundation Symposium 117: 129-148, 1985.
6. Lewy A, Wehr T, Goodwill F et al: Light supresses melatonin secrction in humans. Science 210: 1267-1269, 1980.
7. Tamarkin L, Baird C, Almeida O: Melatonin: a coordinating signal for mammalian reproduction? Science 227: 714-720, 1985.
8. Moore-Ede M, Moline M: Circadian rhythms and photoperiodism. In: Photoperiodism, melatonin and the pineal, Ciba Foundation Symposium 117: 23-37, 1985.
9. Leung F, Cornélissen G, Hillman D, Wang Z, Binkley S, Bingham C and Halberg F: Halting steps toward a circadian-infradian pineal melatonin chronome. In: Chronobiology and Chronomedicine (Halberg F and Watanahe H, eds.),Tokio, Medical Review Ltd, 1992, pp. 263-285.
10. Halberg F: The Week in Phylogeny and Ontogeny: Opportunities for Oncology. In Vivo (1995); 9: 269-278.
11. Cornélissen G, Portela A, Halberg F, Bolliet V, Falcon J: Toward a chronome of superfused pike pineals: about-weekly (circaseptan) modulation of circadian melatonin release. In Vivo, in press.
12. Sanchez de la Peña S, Halberg F and Ungar F: Pineal chronomodulation: the feed-sideward. Clin.Chem.Newslett. 2: 129-130, 1982.
13. Sanchez de la Peña S: The feedsideward of cephalo-adrenal immune interactions. Chronobiologia 20(1-2): 1-52 1993.
14. Engel P: über den Einfluss von Hypophysenvorderlappenhormonen und Epihormonen auf das Wachstum von Impftumoren. Z.Krebsforsch. 4: 281-291, 1934.
15. Engel P: Wachstumbeeinflussende Hormone und Tumorwachstum. Z. Krebsforsch. 41: 488-496, 1935.
16. Hofstätter R: Beitrag zur therapeutischen Verwendung von Zirbelextrakten. Wien Klin Wschr 62: 338-339, 1950.
17. Aubert C, Janiaud P and Lecalvez J: Effect of pinealectomy and melatonin on mammary tumor growth in Sprague-Dawley rats under different conditions of lighting. J Neural Transm 47: 121-130, 1980.
18. Barone RM and Das Gupta TK: Role of the pinealectomy on Walker 256 carcinoma in rats. J Surg Oncol 2: 313-322, 1970.
19. Das Gupta TK and Terz J: Influence of pineal gland on the growth and spread of melanoma in the hamster. Cancer Res 27: 1306-1311, 1967.
20. Lapin V: Influence of simultaneous pinealectomy and thymectomy on the growth and formation of metastases of the Yoshida sarcoma in rats. Exp Pathol 9: 108-112, 1974.
21. Rodin AE: The growth and spread of Walker 256 carcinoma in pinealectomized rats. Cancer Res 23: 1545-1550, 1963.
22. Wrba H, Lapin V and Dostal V: The influence of pinealectomy and of pinealectomy combined with thymectomy on the oncogenesis caused by polyoma virus in rats, ôsterreichische Z Onkol 2: 37-39, 1975.
23. Anisimov VN, Khavinson VKh: The use of peptide preparations of the epiphysis (pineal gland) in oncology: 20 years' experience of research on epithalamin. Vopr-Onkol. 39(4-6): 131-42 1993 (in Russian).
24. Anisimov VN, Bondarenko LA, Khavinson VKh: Effect of pineal peptide preparation (epithalamin) on life span and pineal and serum melatonin level in old rats. Ann NY Acad Sci 673: 53-7 1992.
25. Blask D: The pineal: an oncostatic gland? In: Reiter RJ Ed. The pineal gland. New York, Raven 1984; 253-384.
26. Cohen M, Lippman M, Chabner B: Role of pineal gland in aetiology and treatment of breast cancer. Lancet 1978; 2:814-816.
27. Blask D, Lemus-Wilson A , Wilson S: Breast cancer: a model system for studying the neuroendocrine role of pineal melatonin in oncology. Biochem-Soc- Trans 20(2): 309-11, 1992.
28. Halberg F, Haus E, Halberg E, Berg H, Cornélissen G: Sphygmoneuroimmunomodulation (S-NIM):multifrequency feed-sidewards among the circulation, cancer and melatonin. Chronobiologia 21/1-2 (143) 1994.
29. Langevin T, Hrushesky W, Sanchez S and Halberg F: Melatonin modulates survival of CD2F1 mice with L1210 leukemia. Chronobiologia 10: 173-174, 1983.
30. Sanchez de la Pena S, Halberg F, Ungar F and Sanchez E: Circadian response of adrenals incubated with pituitaries, hypothalami, pineal homogenate, or ACTH 1-17, Synchrodyn. Abstracts of papers Minn Acad Sci. 50th Annual Spring Meeting, Gustavus Adolphus College, St.Peter, Minn., April 23-24, 1982, p.6.
31. Sanchez de la Pena S, Halberg F, Halberg E, Ungar F, Cornélissen G, Sanchez E, Brown G, Scheving LE, Yunis EG and Vecsei P: Pineal modulaion of ACTH 1-17 effect upon murine corticoslerone production. Brain Res Bull 11: 117-125, 1983.
32. Sanchez de la Pena S, Halberg F, Ungar F, Haus E, Lakatua D, Scheving LE, Sanchez E and Vecsei P: Circadian pineal modulation of pituitary effect on murine costicosterone in vitro. Brain Res Bull 10: 559-565, 1983.
33. Wrba H, Halberg F and Dutter A: Placebo-accelerated murine mammary carcinogenesis slowed by melatonin studied on staggered lighting. Chronobiologia 12: 285, 1985.
34. Wrba H, Halberg F and Dutter A: Melatonin circadian stage-dependently delays breast cancer development in mice injected daily for several months. In: Neuroimmunomodulation. Proc 1st Int Workshop on Neuroimmunomodulation, Bethesda, MD, Nov.27-30, 1984. International Working Group on Neuroimmunomodulation, Bethesda, pp.258-261, 1985.
35. Maestroni G, Conti A, Pierpaoli W: Role of the pineal gland in immunity: circadian synthesis and release of melatonin modulates the antibody response and antagonists immunosuppresive effect of corticosterone. J Neuroimmunol 13: 19-30, 1986.
36. Angeli A, Gatti G, Sartori M et al: Effect of exogenous melatonin on human natural killer (NK) cell activity: an approach to the immunomodulatory role of the pineal gland. In: The Pineal Gland and Cancer (Gupta D, Attanasio A, Reiter RJ eds.) Brain Research Promotion, T'bingen 1988; pp. 145-156.
37. Sandyk R, Mukherjee S: Attenuation of response-induced catalepsy by melatonin and the role of the opioid system. Int J Neurosci 48: 297-301, 1989.
38. Shellard S, Whelan R, Hill B: Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumor cell lines in vitro. Br J Cancer 60: 288-290, 1989.
39. Viviani S, Bidoli P, Spinazze S et al: Normalization of the light/ dark rhythm of melatonin after prolonged subcutaneous administration of Interleukin-2 in advanced small cell lung cancer patients. J Pineal Res 12(3): 114-117, 1992.
40. Bartsch C, Bartsch H, Fluchter SH, Mecke D, Lippert TH: Diminished pineal function coincides with disturbed circadian endocrine rhythmicity in untreated primary cancer patients: Consequence of premature aging or of tumor growth? Ann NY Acad Sci 719: 502-25, 1994.
41. Lissoni P, Crispino S, Barni S et al: Pineal gland and tumor cell kinetics: serum levels of melatonin in relation to Ki-67 labeling rate in breast cancer. Oncology 47: 275-277, 1990.
42. Bartsch C, Bartsch H, Fluchter S et al: Evidence for modulation of melatonin secretion in men with benign and malignant tumors of the prostate. Relationship with the pituitary hormones. J Pineal Res 2: 121-132, 1985.
43. Bartsch C, Bartsch H, Schmidt A et al: Melatonin and 6-Sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations. Clin Chim Acta 209(3): 153-167, 1992.
44. Bartsch C, Bartsch H, Fuchs U et al: Stage-dependent depression of melatonin in patients with primary breast cancer. Cancer 64: 426- 433, 1989.
45. Dogliotti L, Torta M, Berruti A et al: Melatonin relationship to human tumors. In: Gupta D, Attanasio A, Reiter RJ (Eds). The pineal gland and cancer. Tübingen, Brain Research Promotion: 167-181, 1988.
46. Cornélissen G, Berg H, Haus E, Halberg F: Chronome of urinary 6-sulfoxy-melatonin excretion, circulating CA125, cancer progression and therapeutic response. In Vivo, in press.
47. Stevens R, Davis S, Thomas D et al: Electric power, pineal function and the risk of breast cancer. FASEB J 6: 853-860, 1992.
48. Wilson B, Stevens R, Anderson L: Neuroendocrine mediated effects of electromagnetic field exposure: possible role of the pineal gland. Life Sciences 45: 1319-1332, 1989.
49. Welker H, Semm P, Willig R: Effects of an artificial magnetic field on scrotonin N-acetiltransferase activity and melatonin content of the rat pineal gland. Exp Brain Res 50: 426-432, 1983.
50. Wilson B, Anderson L, Hilton D et al: Chronic exposure to 60-Hz electric fields: effects on pineal function in the rat. Bioelectromagnetics 4: 293, 1983.
51. Bowman J, Carabrant D, Sobel E et al: Exposures to ELF electromagnetic fields in occupations with elevated leukemia rates. Appl Ind Hyg 3: 189-194, 1988.
52. Deadman J, Camus M, Armstron B et al. Occupational and residential 60-Hz electromagnetic fields and high-frequency electric transients: exposure assessment using a new dosimeter.Am Ind Hyg Assoc J 49: 409-419, 1988.
53. Florig H, Hoburg J, Morgan M: Electric field exposure from electric blankets. IEEE Trans P Del PWRD 2: 527-536, 1987.
54. Ehret C, Rosenberg R, Sacher G et al: Biomedical effects associated with energy transmission systems: effects of 60-Hz electric fields and circadian and ultradian physiological and behavioral function in small rodents. Annual Report, U.S. Dept. of Energy, Division of Electric Energy Systems, Washington D.C. 1980.
55. Reiter RJ, Anderson LE, Buschbom RL, Wilson BW: Reduction of the nocturnal rise in pineal melatonin levels in rats exposed to 60 Hz electric fields in utero and for 23 days after birth. Life Sci 42: 2203, 1988.
56. Cleary SF: A review of in vitro studies: Low-frequency electromagnetic fields. Am Ind Hyg Assoc J 54(4): 178-85, 1993.
57. Liburdy RP, Sloma TR, Sokolic R, Yaswen P: ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin's oncostatic action on ER(+) breast cancer cell proliferation. J-Pineal-Res 14(2): 89-97, 1993.
58. Gandhi O, Sedigh K, Beck G et al: Distribution of electromagnetic energy deposition in models of man with frequencies near resonance. In: Biological effects of electromagnetic waves. Selected papers of the USNC/URSI Annual Meeting. Boulder (Colorado). October 20-23, 1975. U.S. Dept. of Health, Educ. and Welfare Publ. (FDA) 1976: II:44-67.
59. Albert E, Desantis M: Histological observations on Central Nervous System. In: Biological effects of Electromagnetic Waves, Selected papers of the USNC/URSI Annual Meeting, Boulder (Colorado), October 20-23, 1975. U.S. Dept. of Health, Education and Welfare Publication (FDA) 1976; I: 299- 310.
60. Schatzkin A, Jones D, Hoover R et al: Alcohol consumption and breast cancer in the epidemiologic follow-up study of the First National health and nutrition examination Survey. N Eng J Med 316: 1169-1173, 1987.
61. Willett W, Stampfer M, Colditz G et al: Moderate alcohol consumption and risk of breast cancer. N Eng J Med 316: 1174-1180, 1987.
62. Hiatt R, Bawol R: Alcoholic beverage consumption and breast cancer. Am J Epidemiol 120: 676-683, 1984.
63. Stevens R, Hiatt R: Alcohol, melatonin and breast cancer. N Eng J Med 317: 1287, 1987.
64. Beck-Friis J, Von Rosen D, Kjelmman B et al: Melatonin in relation to body measures, sex, age, season, and the use of drugs in patients with major affective disorders and healthy subjects. Psychoncuroendoc 9: 261-277, 1984.
65. Cohen M, Wax Y, Modan B: Seasonality in the occurrence of breast cancer. Cancer Res 43: 892-896, 1983.
66. Lee J: Seasonal alterations and the natural history of malignant neoplasms. In: Ariel I.(Ed) Progress in clinical cancer, New York, Grune and Stratton 1967; III:96-106.
67. Mason B, Holdaway I, Stewart A et al: Season of initial discovery of tumor as an independent variable predicting survival in breast cancer. Br J Cancer 61: 137-141, 1990.
68. Piccoli B, Parazzoli S, Zaniboni A, Demartini G, Fraschini F: Nonvisual effects of light mediated via the optical route: a survey of the literature and implications for occupational medicine. Med Lav 82; 3: 213-232, 1991 (in Italian).